UNLIMITED TURBO LONG - MERCK & CO. | Real-time Euronext Paris 03:32:44 2024-07-16 am EDT | ||
| 4.712 EUR | +1.49% |
|
| Current month | -3.47% | ||
| 1 month | -4.95% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 4.712 | +1.49% |
| 24-07-15 | 4.643 | -0.75% |
| 24-07-12 | 4.678 | -0.02% |
| 24-07-11 | 4.679 | +1.65% |
| 24-07-10 | 4.603 | +3.25% |
Real-time Euronext Paris
Last update July 16, 2024 at 03:32 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| QG6MB | |
| ISIN | NLBNPNL2LZC0 |
| Date issued | 2024-01-04 |
| Strike | 78.39 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.41 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.374 € |
|---|---|
| Lowest since issue | 3.62 € |
| Spread | 0.106 € |
| Spread % | 2.22% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.1
USD
Average target price
142.7
USD
Spread / Average Target
+11.35%
- Stock Market
- Certificates
- QG6MB Certificat
